The first American woman to receive a vaccine scientists hope will prevent recurring bouts of an aggressive type of breast said it has changed her life. Jennifer Davis, a 46-year-old nurse and mom of three from was the first of 15 women in a clinical trial to have received the three-dose series of the vaccine as part of a Cleveland Clinic-run study, which involves patients who completed chemotherapy treatment for a specific form of breast cancer in the past three years.In 2018, Ms Davis was , a form of the disease that makes up about 10 to 15 percent of breast cancer cases that can reoccur in between bouts of remission.
Load More
Load More